The Effect of Linagliptin on Mitochondrial and Endothelial Function

Trial Profile

The Effect of Linagliptin on Mitochondrial and Endothelial Function

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2016

At a glance

  • Drugs Linagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Nov 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
    • 01 Sep 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top